Institute of Biomembranes and Bioenergetics
Nicoletta Guaragnella has not added Biography.
If you are Nicoletta Guaragnella and would like to personalize this page please email our Author Liaison for assistance.
D-Lactate transport and metabolism in rat liver mitochondria.
The Biochemical journal Jul, 2002 | Pubmed ID: 11955284
ATO3 encoding a putative outward ammonium transporter is an RTG-independent retrograde responsive gene regulated by GCN4 and the Ssy1-Ptr3-Ssy5 amino acid sensor system.
The Journal of biological chemistry Nov, 2003 | Pubmed ID: 12966084
Acid stress adaptation protects Saccharomyces cerevisiae from acetic acid-induced programmed cell death.
Gene Jul, 2005 | Pubmed ID: 15894436
YCA1 participates in the acetic acid induced yeast programmed cell death also in a manner unrelated to its caspase-like activity.
FEBS letters Dec, 2006 | Pubmed ID: 17156780
Catalase T and Cu,Zn-superoxide dismutase in the acetic acid-induced programmed cell death in Saccharomyces cerevisiae.
FEBS letters Jan, 2008 | Pubmed ID: 18082141
A transient proteasome activation is needed for acetic acid-induced programmed cell death to occur in Saccharomyces cerevisiae.
FEMS yeast research May, 2008 | Pubmed ID: 18218016
Cytochrome c is released from coupled mitochondria of yeast en route to acetic acid-induced programmed cell death and can work as an electron donor and a ROS scavenger.
FEBS letters Apr, 2008 | Pubmed ID: 18396162
Yeast acetic acid-induced programmed cell death can occur without cytochrome c release which requires metacaspase YCA1.
FEBS letters Jan, 2010 | Pubmed ID: 19941863
Knock-out of metacaspase and/or cytochrome c results in the activation of a ROS-independent acetic acid-induced programmed cell death pathway in yeast.
FEBS letters Aug, 2010 | Pubmed ID: 20674572
Cytochrome c Trp65Ser substitution results in inhibition of acetic acid-induced programmed cell death in Saccharomyces cerevisiae.
Mitochondrion Nov, 2011 | Pubmed ID: 21907312
Achievements and perspectives in yeast acetic acid-induced programmed cell death pathways.
Biochemical Society transactions Oct, 2011 | Pubmed ID: 21936848
Yeast as a tool to study signaling pathways in mitochondrial stress response and cytoprotection.
TheScientificWorldJournal , 2012 | Pubmed ID: 22454613
The role of mitochondria in yeast programmed cell death.
Frontiers in oncology , 2012 | Pubmed ID: 22783546
The N-acetylcysteine-insensitive acetic acid-induced yeast programmed cell death occurs without macroautophagy.
Current pharmaceutical biotechnology Dec, 2012 | Pubmed ID: 23072389
Stress-related mitochondrial components and mitochondrial genome as targets of anticancer therapy.
Chemical biology & drug design Jan, 2013 | Pubmed ID: 23253132
Molecular mechanisms of Saccharomyces cerevisiae stress adaptation and programmed cell death in response to acetic acid.
Frontiers in microbiology , 2013 | Pubmed ID: 23430312
Yeast growth in raffinose results in resistance to acetic-acid induced programmed cell death mostly due to the activation of the mitochondrial retrograde pathway.
Biochimica et biophysica acta Dec, 2013 | Pubmed ID: 23906793
The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2.
FEMS yeast research Feb, 2014 | Pubmed ID: 24103154
Silencing of BRCA2 decreases anoikis and its heterologous expression sensitizes yeast cells to acetic acid-induced programmed cell death.
Apoptosis : an international journal on programmed cell death Sep, 2014 | Pubmed ID: 24902638
Mitochondrial dysfunction in cancer chemoresistance.
Biochemical pharmacology Nov, 2014 | Pubmed ID: 25107705
Yeast as a tool to study mitochondrial retrograde pathway en route to cell stress response.
Methods in molecular biology (Clifton, N.J.) , 2015 | Pubmed ID: 25634284
Differential proteome-metabolome profiling of YCA1-knock-out and wild type cells reveals novel metabolic pathways and cellular processes dependent on the yeast metacaspase.
Molecular bioSystems Jun, 2015 | Pubmed ID: 25697364
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。